Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Haemacure reports third quarter revenues of $31,409 and updates Hemaseel project
October 5th, 2006
Haemacure Corp. (HAE) released the results of its third quarter ended July 31, 2006 and reported on its Hemaseel project. Revenues totaled $31,409, down from previous year. During the quarter, Haemacure continued to expend important efforts towards raising the capital required for the completion of its Hemaseel project. Delays in securing the required financing have resulted in delays in the construction of the facility and the procurement of equipment. In addition, as a result of such delays, Haemacure expects an increase in the overall cost of its project. Haemacure will be able to assess this increase only when the financing is secured. If and...
Source: Blood Weekly (2006-10-05)
|
